Medinet CoTSE:2370 41 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates TSE:2370 with a GF Score™ of 41/100 and a GF Value™ of 円41.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 950 Biotechnology companies, Medinet Co ranks worse than 59.37% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medinet Co's Free Cash Flow for the
three
months ended in Mar. 2026 was 円0.0 Mil. Medinet Co's Revenue for the
three
months ended in Mar. 2026 was 円232.9 Mil. Therefore, Medinet Co's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Medinet Co's FCF Margin % or its related term are showing as below:
TSE:2370'
s FCF Margin % Range Over the Past 10 Years
Min: -284.36 Med: -160.42 Max: -59.99
Current: -176.41
During the past 13 years, the highest FCF Margin % of Medinet Co was -59.99%. The lowest was -284.36%. And the median was -160.42%.
TSE:2370's FCF Margin % is ranked worse than 59.37% of 950
companies
in the Biotechnology industry
Industry Median: -84.535
vs TSE:2370: -176.41
Medinet Co FCF Margin % Related Terms
Medinet Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Medinet Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2370 vs VRTX, REGN, ALNY: FCF Margin % Comparison
For the Biotechnology subindustry, Medinet Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medinet Co FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Medinet Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medinet Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medinet Co (TSE:2370) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medinet Co and its competitors. According to the industry distribution chart, Medinet Co ranks #564 out of 950 companies in the Biotechnology industry, placing it in the top 59.4%.
Is Medinet Co's FCF Margin % too high?
Medinet Co's current FCF Margin % is 0.00%. Based on the distribution chart, Medinet Co ranks #564 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Medinet Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medinet Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medinet Co ranks #564 out of 950 companies for FCF Margin %. This places Medinet Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medinet Co and its competitors. Medinet Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medinet Co stock overvalued right now?
Based on GuruFocus' analysis, Medinet Co (TSE:2370) is currently considered Possible Value Trap. The stock's GF Value™ is 円41.74, compared to a current price of 円25.00 — trading 40.1% below its estimated fair value. The current FCF Margin % is 0.00%. Medinet Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medinet Co (TSE:2370), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medinet Co (TSE:2370) Overvalued in 2026?
Based on GuruFocus' analysis, Medinet Co stock appears to be undervalued.
The current stock price of 円25.00 is trading 40.1% below its estimated GF Value™ of 円41.74.
GuruFocus considers Medinet Co to be Possible Value Trap.
Key valuation signals for TSE:2370:
FCF Margin %: 0.00%
GF Value™: 円41.74 vs. price of 円25.00 (40.1% below fair value)
No single metric tells the full story. See the TSE:2370 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.
41GF Score
Get the complete analysis for TSE:2370
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2370 has been successfully added to your 
